May 24, 2007
Commentary by Seagram Villagomez MD, Chief Resident
Since its approval in 1999, nearly 1 million Americans have used the thiazolidinedione (TZD) rosiglitazone (Avandia – GlaxoSmithKline) for the treatment of Type 2 Diabetes. However, in a drug class which seems plagued by…
Read the rest of this entry >>
Posted in Endocrine, Journal Club, Pharmacology
April 24, 2007
By: Alana Choy-Shan, MD PGY-3
Transient ischemic attacks (TIAs) are known to be a harbinger of stroke, however it is difficult for physicians to estimate individual stroke risk. Previously, the two systems used to predict short-term risk of stroke after a…
Read the rest of this entry >>
Posted in Journal Club, Neuro
April 12, 2007
Commentary By: Margaret Horlick, MD, PGY-3
New guidelines on the diagnosis and treatment of venous thromboembolism (VTE) were recently jointly issued by the American Academy of Family Physicians and the American College of Physicians. The guidelines are based on a systematic…
Read the rest of this entry >>
Posted in Heme/Onc, Journal Club, Pulmonary/Critical Care
April 10, 2007
Commentary By: Anna Dvorak, MDPGY-3
Lung cancer is the number one cause of cancer mortality in both men and women. Screening patients at risk for lung cancer might reduce mortality if it helps find cancers at an early stage while they…
Read the rest of this entry >>
Posted in Journal Club, Pulmonary/Critical Care
March 12, 2007
Commentary By: Danise Schiliro, PGY-3
Although intuitively we always worry about creating drug resistance when using antibiotics, there is a surprising lack of well done studies that show a clear causal effect of antibiotic use on the development of subsequent drug…
Read the rest of this entry >>
Posted in ID, Journal Club, Pharmacology
February 16, 2007
Commentary By: Joshua Olstein PGY-3
Second only to lung cancer, colon cancer claimed an estimated 55,000 lives in the United States in 2006. In an effort to reduce colon cancer morbidity and mortality, multiple screening tests have been developed to detect…
Read the rest of this entry >>
Posted in GI, Journal Club
January 24, 2007
Commentary By: Sandra D'Angelo, PGY-3
Nonalcoholic steatohepatitis (NASH) is a disease in which patients have features of alcoholic hepatitis on liver biopsy without a prior history of significant alcohol consumption and negative hepatitis serologies. It is unclear how prevalent this disease…
Read the rest of this entry >>
Posted in GI, Journal Club
December 22, 2006
In a recent article in the Lancet, this question was addressed by a group of investigators led by Sue Moss, Ph.D. from the University of Leeds. Currently, the National Cancer Institute, U.S. Preventative Health Services Task Force and the American…
Read the rest of this entry >>
Posted in Heme/Onc, Journal Club
November 29, 2006
In the November 22nd issue of JAMA, the results of two studies from the Spine Patient Outcomes Research Trial (SPORT) on lumbar disk surgery for persistent radicular pain are reported. Both these studies sought to assess the efficacy of surgery…
Read the rest of this entry >>
Posted in Journal Club, Neuro
November 17, 2006
Read the rest of this entry >>
Posted in Journal Club, Renal
November 16, 2006
Reperfusion via thrombolytics or PCI in patients with acute STEMI has been shown to reduce…
Read the rest of this entry >>
Posted in Breaking News, Cardiology, Journal Club
